|
USP36 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.66509037061269E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.38999939231144E-11 |
| Normal-vs-Stage2 |
4.33899999999765E-05 |
| Normal-vs-Stage3 |
4.60609328456485E-12 |
| Normal-vs-Stage4 |
1.2906000046442E-08 |
| Stage1-vs-Stage2 |
3.129000E-01 |
| Stage1-vs-Stage3 |
1.143950E-01 |
| Stage1-vs-Stage4 |
6.945800E-01 |
| Stage2-vs-Stage3 |
5.382200E-02 |
| Stage2-vs-Stage4 |
2.713200E-01 |
| Stage3-vs-Stage4 |
4.505800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.17810206035074E-11 |
| Normal-vs-AfricanAmerican |
1.50174999999919E-05 |
| Normal-vs-Asian |
4.02659999998445E-06 |
| Caucasian-vs-AfricanAmerican |
9.396800E-01 |
| Caucasian-vs-Asian |
2.761400E-01 |
| AfricanAmerican-vs-Asian |
4.769200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.23239998603719E-10 |
| Normal-vs-Female |
4.48285852883146E-12 |
| Male-vs-Female |
7.841200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.24119953099E-10 |
| Normal-vs-Age(41-60Yrs) |
1.97679983493515E-10 |
| Normal-vs-Age(61-80Yrs) |
4.37779812401118E-11 |
| Normal-vs-Age(81-100Yrs) |
7.993600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.161800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.141200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.319600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.964600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.322200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.197000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.000550E-03 |
| Classical-VS-Follicular |
6.707700E-02 |
| Classical-VS-Other |
2.323000E-01 |
| Classical-VS-Normal |
3.92930021853033E-10 |
| Tall-VS-Follicular |
2.030400E-01 |
| Tall-VS-Other |
8.525600E-01 |
| Tall-VS-Normal |
1.80949699668531E-11 |
| Follicular-VS-Other |
6.989400E-01 |
| Follicular-VS-Normal |
5.59760005014454E-09 |
| Other-VS-Normal |
7.563100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.27350035966845E-10 |
| Normal-vs-N1 |
4.2775999964384E-08 |
| N0-vs-N1 |
5.306800E-01 |
|
|
